Literature DB >> 18408466

Genetics of biliary tract diseases: new insights into gallstone disease and biliary tract cancers.

Aksana Höblinger1, Frank Lammert.   

Abstract

PURPOSE OF REVIEW: Chronic biliary diseases are due to complex interactions between environmental and genetic factors. Here we summarize the current knowledge of genetic factors that contribute to common biliary diseases, focusing on gallstones and carcinogenesis, and review the recent association studies. RECENT
FINDINGS: Since most studies were based on small sample sizes, replication of the findings is mandatory. Recently a large twin study confirmed a genetic predisposition to gallstones and a genome-wide association scan identified the hepatocanalicular cholesterol transporter ABCG8 as the common susceptibility factor for gallstone disease. Genetic studies in patients with cholangiocarcinoma indicate that genes controlling the metabolism and transport of xenobiotics or modulating chronic inflammation may determine individual susceptibility.
SUMMARY: Genetic studies have identified the first susceptibility factors for gallstones and biliary tract cancers, but most results have yet to be replicated. In the future, genome-wide studies in different populations are likely to identify the entire set of genes contributing to chronic biliary diseases. Since the disease phenotypes result from the manifestation of susceptibility factors under the influence of environmental triggers, the discovery of these genes will open avenues to control environmental challenges and lead to novel strategies for risk assessment ('gene signatures') and prevention.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18408466     DOI: 10.1097/MOG.0b013e3282f79b32

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  6 in total

1.  Gallbladder cancer: the basics.

Authors:  Eldon A Shaffer
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-10

2.  Description of two new ABCB11 mutations responsible for type 2 benign recurrent intrahepatic cholestasis in a French-Canadian family.

Authors:  Yannick Beauséjour; Fernando Alvarez; Martin Beaulieu; Marc Bilodeau
Journal:  Can J Gastroenterol       Date:  2011-06       Impact factor: 3.522

3.  Potential genotype-specific single nucleotide polymorphism interaction of common variation in p53 and its negative regulator mdm2 in cholangiocarcinoma susceptibility.

Authors:  Vincent Zimmer; Aksana Höblinger; Florentina Mihalache; Gunter Assmann; Monica Acalovschi; Frank Lammert
Journal:  Oncol Lett       Date:  2012-04-17       Impact factor: 2.967

4.  XRCC1 Arg194Trp and Arg399Gln polymorphisms and risk of extrahepatic cholangiocarcinoma: a hospital-based case-control study in China.

Authors:  Yuanfeng Gong; Ming Qi; Jun Chen; Runya Fang; Cong Mai; Tiejun Chen; Hui Tang; Yunqiang Tang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

5.  Effects of SLC10A2 variant rs9514089 on gallstone risk and serum cholesterol levels- meta-analysis of three independent cohorts.

Authors:  Anke Tönjes; Henning Wittenburg; Jan Halbritter; Olga Renner; Simone Harsch; Eduard F Stange; Frank Lammert; Michael Stumvoll; Peter Kovacs
Journal:  BMC Med Genet       Date:  2011-11-17       Impact factor: 2.103

6.  High incidence of cholesterol gallstone disease in type 1 Gaucher disease: characterizing the biliary phenotype of type 1 Gaucher disease.

Authors:  Tamar H Taddei; James Dziura; Shu Chen; Ruhua Yang; Hideyuki Hyogo; Cameron Sullards; David E Cohen; Gregory Pastores; Pramod K Mistry
Journal:  J Inherit Metab Dis       Date:  2010-03-31       Impact factor: 4.982

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.